Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives

T Lazarević, A Rilak, ŽD Bugarčić - European journal of medicinal chemistry, 2017 - Elsevier
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the
metal, its oxidation state, the types and number of coordinated ligands and the coordination …

Anti-cancer palladium complexes: a focus on PdX 2 L 2, palladacycles and related complexes

AR Kapdi, IJS Fairlamb - Chemical Society Reviews, 2014 - pubs.rsc.org
Much success has been achieved with platinum-based chemotherapeutic agents, ie through
interactions with DNA. The long-term application of Pt complexes is thwarted by issues …

Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin

AS Abu-Surrah, M Kettunen - Current medicinal chemistry, 2006 - ingentaconnect.com
In the next two decades, the world is expected to see around 20 million cases of cancer.
Moreover, the types of cancer will vary considerably from country to other. Therefore, all …

Anticancer activity of palladium-based complexes against triple-negative breast cancer

M Vojtek, MPM Marques, IM Ferreira, H Mota-Filipe… - Drug Discovery …, 2019 - Elsevier
Highlights•TNBC is an unmet medical need with poor survival rates and no targeted
therapy.•TNBC resists conventional chemotherapy and surgical strategies.•A review of 121 …

Comprehensive review on tumour active palladium compounds and structure–activity relationships

MN Alam, F Huq - Coordination Chemistry Reviews, 2016 - Elsevier
This article provides a comprehensive review of palladium compounds that have been
evaluated for anticancer activity in vivo or in vitro from the era of discovery of cisplatin up to …

[PDF][PDF] Palladium-based chemotherapeutic agents: Routes toward complexes with good antitumor activity

AS Abu-Surrah, HH Al-Sa'doni, MY Abdalla - Cancer Ther, 2008 - academia.edu
Summary Chemical-, pharmacological-, and clinical-research on anticancer coordination
complexes has yielded remarkable anticancer agents such as cisplatin, carboplatin, and …

Platinum and palladium polyamine complexes as anticancer agents: the structural factor

MPM Marques - International Scholarly Research Notices, 2013 - Wiley Online Library
Since the introduction of cisplatin to oncology in 1978, Pt (II) and Pd (II) compounds have
been intensively studied with a view to develop the improved anticancer agents. Polynuclear …

Palladium (II) compounds with potential antitumour properties and their platinum analogues: a comparative study of the reaction of some orotic acid derivatives with …

JL Butour, S Wimmer, F Wimmer, P Castan - Chemico-Biological …, 1997 - Elsevier
Ethidium bromide was used to study perturbations induced in salmon sperm DNA
complexed with a series of platinum and palladium compounds obtained from chloro and …

Selective platination of biologically relevant polyamines. Linear coordinating spermidine and spermine as amplifying linkers in dinuclear platinum complexes

H Rauter, R Di Domenico, E Menta, A Oliva… - Inorganic …, 1997 - ACS Publications
A new approach to the synthesis of novel bifunctional dinuclear platinum complexes with
linear coordinating spermidine and spermine is reported. The synthetic pathway involves …

Probing the dynamic thermodynamic resolution and biological activity of Cu (II) and Pd (II) complexes with Schiff base ligand derived from proline

T Yu, VA Soloshonok, Z Xiao, H Liu, J Wang - Chinese Chemical Letters, 2024 - Elsevier
Schiff base metal complexes are of great importance in pharmaceutical science owing to
their unique chemical properties, which enable them to exhibit diverse biological activities …